ROSEN Encourages Immutep Ltd Shareholders to Secure Legal Counsel Ahead of Important Securities Class Action Deadline

NEW YORK, May 2026 – International investor rights law firm ROSEN has issued an important reminder to investors of Immutep Ltd (NASDAQ: IMMP) regarding an ongoing securities class action lawsuit. The legal action concerns investors who purchased or otherwise acquired Immutep securities during the designated class period and may have suffered financial losses due to alleged misleading statements made by the company.

Investors Warned About Upcoming Lead Plaintiff Deadline

According to the announcement, investors who bought shares of Immutep Ltd during the relevant class period are encouraged to seek legal counsel before the upcoming lead plaintiff deadline. ROSEN emphasized that investors who suffered substantial losses may be eligible to participate in the class action lawsuit and potentially recover damages.

The law firm noted that becoming a lead plaintiff is not required to receive compensation. However, investors who wish to play a more active role in directing the litigation must file the necessary motion with the court before the official deadline.

Allegations Against Immutep Ltd

The securities class action lawsuit alleges that Immutep Ltd may have issued materially misleading statements and failed to disclose critical information to investors. The complaint claims that the company made statements regarding its business operations, clinical development programs, and overall financial outlook that may not have accurately reflected the actual situation.

As a result of these alleged omissions and misrepresentations, investors reportedly suffered damages when the truth became known to the market, leading to declines in the company’s stock price.

Focus on Investor Protection

ROSEN stated that its goal is to protect shareholders and help investors recover losses caused by potential securities fraud or corporate misconduct. The law firm has extensive experience representing investors in complex class action lawsuits involving publicly traded companies.

The firm also highlighted that investors should select qualified counsel with a successful track record in securities litigation. ROSEN has previously recovered significant settlements on behalf of investors around the world.

What Investors Should Know

Investors who purchased Immutep securities and experienced losses are advised to review their legal rights carefully. Participating in the class action may allow affected shareholders to seek financial recovery if the claims are proven in court.

ROSEN explained that investors can join the lawsuit without any upfront legal fees under a contingency fee arrangement. This means attorneys are only paid if compensation is successfully recovered for shareholders.

Understanding Securities Class Actions

Securities class action lawsuits are typically filed when investors believe a publicly traded company provided false or misleading information that affected stock prices. These lawsuits aim to hold companies accountable and help investors recover losses caused by alleged misconduct.

In cases like this, courts may appoint a lead plaintiff to represent the interests of all affected shareholders throughout the litigation process.

Importance of Timely Action

Legal experts stress that investors should act quickly because securities litigation involves strict filing deadlines. Missing the lead plaintiff deadline could limit an investor’s ability to participate in certain aspects of the case.

ROSEN encouraged affected shareholders to gather relevant trading records, account statements, and documentation related to their investments in Immutep Ltd.

About Immutep Ltd

Immutep Ltd is a biotechnology company focused on developing immunotherapy treatments for cancer and autoimmune diseases. The company has been involved in clinical research programs aimed at advancing innovative therapies using immune system technologies.

Like many biotechnology firms, Immutep’s market value can be heavily influenced by clinical trial results, regulatory developments, and investor expectations regarding future growth.

ROSEN’s Experience in Securities Litigation

ROSEN Law Firm is widely recognized for representing investors in securities class actions and shareholder litigation. The firm has recovered hundreds of millions of dollars for investors and is known for handling cases involving alleged corporate fraud, misleading disclosures, and violations of securities laws.

The firm advises investors to carefully evaluate law firms based on experience, resources, and prior results in securities class action cases.

Potential Outcomes of the Lawsuit

If the lawsuit succeeds, eligible investors could receive compensation for financial losses connected to their Immutep investments. However, the outcome of the litigation remains uncertain, and legal proceedings may take significant time before reaching resolution.

Courts will evaluate evidence, company disclosures, market reactions, and other relevant factors before determining whether securities laws were violated.

How Investors Can Participate

Investors who believe they may qualify for the class action are encouraged to contact legal counsel promptly to discuss their rights and options. Shareholders may also monitor court filings and legal updates related to the case.

Participation in the lawsuit does not necessarily require investors to appear in court personally, as legal representatives typically manage proceedings on behalf of the shareholder class.

Financial Markets Closely Watching the Case

The lawsuit has attracted attention among investors and financial analysts due to the growing scrutiny surrounding disclosure practices in the biotechnology sector. Cases involving clinical-stage biotech companies often draw strong market reactions because investors rely heavily on company statements regarding research progress and product development.

Market observers will likely continue monitoring updates related to the litigation, regulatory disclosures, and any future developments involving Immutep Ltd.

For additional information regarding the lawsuit and investor rights, shareholders may review official court documents and announcements provided by legal counsel involved in the case.

#Immutep #IMMP #SecuritiesClassAction #InvestorRights #SlimScan #GrowthStocks #CANSLIM